New pain drug SBS-1000 takes first step in human safety trial
Knowledge-focused
Completed
This early-stage study tested a single dose of a new drug called SBS-1000 in 48 healthy adults to see if it is safe and how the body handles it. Participants were randomly assigned to receive either the drug or a placebo by IV. The main goal was to check for side effects and meas…
Phase: PHASE1 • Sponsor: Sparian Biosciences, Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC